(S)-2-Amino-3-methoxypropionic acid hydrochloride, 95.0%, 25g

tert-Butyl 3-nitropyrrolidine-1-carboxylate, 95.0%, 5g

Methyl 4-ethynylpyridine-2-carboxylate, 98%, 100mg

(R)-4-Isopropyl-2-(pyrazin-2-yl)-4,5-dihydrooxazole, 97%, 100mg

2-Azetidinone, 1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-, (3R,4S)-, 95%+, 5g

TERT-BUTYL ((1-BENZYL-4-METHYLPIPERIDIN-4-YL)METHYL)CARBAMATE, 95.0%, 1g

Ethyl 4-(4-Chloro-2-methylphenyl)-4-oxobutanoate, 97.0%, 1g

5-Chloro-7-(hydroxy(pyridin-3-yl)methyl)quinolin-8-ol, 98%, 1g

4-Ethylbenzenethiol, 97% +total of isomer, 100g

2-(4-Bromo-2,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

N-METHOXY-N-METHYL-2-(2-NITROPHENYL)ACETAMIDE, 95.0%, 500mg

Hybridisation vial Non-coated, Height, 75 mm, 35 mm, 1 Piece

2-PHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-OL, 95.0%, 1g